Business Description
Stella Pharma Corp
ISIN : JP3399680002
Share Class Description:
TSE:4888: Ordinary SharesDescription
Stella Pharma Corp is a therapeutic drug research and development company. It is focused on the development of boron compounds, particularly used in boron neutron capture therapy (BNCT). The BNCT is a form of cancer radiation therapy for destroying cancer cells.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.63 | |||||
| Equity-to-Asset | 0.68 | |||||
| Debt-to-Equity | 0.36 | |||||
| Debt-to-EBITDA | -1.28 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 5.19 | |||||
| Beneish M-Score | -0.81 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 8.9 | |||||
| 3-Year EPS without NRI Growth Rate | 8.3 | |||||
| 3-Year FCF Growth Rate | 5.1 | |||||
| 3-Year Book Growth Rate | 54.2 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 93.73 | |||||
| 9-Day RSI | 86.11 | |||||
| 14-Day RSI | 78.28 | |||||
| 6-1 Month Momentum % | -10.26 | |||||
| 12-1 Month Momentum % | -23.01 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 16.5 | |||||
| Quick Ratio | 11.9 | |||||
| Cash Ratio | 11.33 | |||||
| Days Inventory | 7839.37 | |||||
| Days Sales Outstanding | 106.46 | |||||
| Days Payable | 777.7 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2.9 | |||||
| Shareholder Yield % | 1.57 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 82.76 | |||||
| Operating Margin % | -303.33 | |||||
| Net Margin % | -301.14 | |||||
| FCF Margin % | -337.28 | |||||
| ROE % | -27.9 | |||||
| ROA % | -18.53 | |||||
| ROIC % | -53.25 | |||||
| ROC (Joel Greenblatt) % | -71.53 | |||||
| ROCE % | -19.72 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 42.36 | |||||
| PB Ratio | 4.1 | |||||
| Price-to-Tangible-Book | 4.18 | |||||
| EV-to-EBIT | -12.28 | |||||
| EV-to-EBITDA | -12.28 | |||||
| EV-to-Revenue | 36.77 | |||||
| EV-to-FCF | -10.03 | |||||
| Price-to-Net-Current-Asset-Value | 4.42 | |||||
| Price-to-Net-Cash | 8.38 | |||||
| Earnings Yield (Greenblatt) % | -8.13 | |||||
| FCF Yield % | -7.84 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Stella Pharma Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 254.091 | ||
| EPS (TTM) (円) | -25.313 | ||
| Beta | 1.53 | ||
| Volatility % | 28.31 | ||
| 14-Day RSI | 78.28 | ||
| 14-Day ATR (円) | 11.822039 | ||
| 20-Day SMA (円) | 300.45 | ||
| 12-1 Month Momentum % | -23.01 | ||
| 52-Week Range (円) | 229 - 361 | ||
| Shares Outstanding (Mil) | 31.23 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Stella Pharma Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Stella Pharma Corp Stock Events
| Event | Date | Price(円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Stella Pharma Corp Frequently Asked Questions
What is Stella Pharma Corp(TSE:4888)'s stock price today?
The current price of TSE:4888 is 円350.00. The 52 week high of TSE:4888 is 円361.00 and 52 week low is 円229.00.
When is next earnings date of Stella Pharma Corp(TSE:4888)?
The next earnings date of Stella Pharma Corp(TSE:4888) is .
Does Stella Pharma Corp(TSE:4888) pay dividends? If so, how much?
Stella Pharma Corp(TSE:4888) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers